MR编号 | FR/H/0341/001 |
---|
药品名称 | AZZALURE 125 Speywood units |
---|
活性成分 | - Clostridium botulinum type A neurotoxin complex 0.0 0
|
---|
剂型 | Powder for solution for injection |
---|
上市许可持有人 | Beaufour Ipsen Pharma
24 rue Erlanger
75016 Paris |
---|
参考成员国 - 产品名称 | France (FR) |
---|
互认成员国 - 产品名称 | - Slovakia (SK)
- Croatia (HR)
- Hungary (HU)
AZZALURE 10 Speywood egység/0,05 ml por oldatos injekcióhoz - Latvia (LV)
- Lithuania (LT)
Azzalure 125 Speywood vienetai milteliai injekciniam tirpalui - Estonia (EE)
- Bulgaria (BG)
Azzalure - Romania (RO)
- Slovenia (SI)
- Malta (MT)
- Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Cyprus (CY)
- Czechia (CZ)
|
---|
许可日期 | 2009/01/28 |
---|
最近更新日期 | 2025/01/24 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Biological: Other
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|